MedPath
TGA Approval

ANORO ELLIPTA 62.5/25 umeclidinium (as bromide)/vilanterol (as trifenatate) 62.5 microgram/25 microgram powder for inhalation (207529)

207529

ANORO ELLIPTA 62.5/25 umeclidinium (as bromide)/vilanterol (as trifenatate) 62.5 microgram/25 microgram powder for inhalation

GlaxoSmithKline Australia Pty Ltd

July 4, 2014

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/debed1b14ad8f96903827e0c29577195.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/a66438d06a022c48bece939e2df2b4d8.pdf

Active Ingredients

umeclidinium bromide

vilanterol trifenatate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ANORO ELLIPTA 62.5/25 umeclidinium (as bromide)/vilanterol (as trifenatate) 62.5 microgram/25 microgram powder for inhalation (207529) - TGA 批准文号 | MedPath